Cebpa | Rat | (+)-artemisinic acid | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | [artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA and artemisic acid results in decreased expression of CEBPA mRNA | CTD | PMID:23063590 |
Cebpa | Rat | (+)-artemisinic acid | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol | CTD | PMID:23063590 |
Cebpa | Rat | (+)-pilocarpine | multiple interactions | EXP | | 6480464 | [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] | CTD | PMID:32494933 |
Cebpa | Rat | (-)-cotinine | multiple interactions | EXP | | 6480464 | [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein | CTD | PMID:29617909 |
Cebpa | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | epigallocatechin gallate inhibits the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein] | CTD | PMID:20438794 |
Cebpa | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CEBPA mRNA | CTD | PMID:36331819 |
Cebpa | Rat | (S)-nicotine | multiple interactions | EXP | | 6480464 | [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein | CTD | PMID:29617909 |
Cebpa | Rat | (S)-nicotine | affects expression | EXP | | 6480464 | Nicotine affects the expression of CEBPA mRNA | CTD | PMID:31972234 |
Cebpa | Rat | (S)-nicotine | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Nicotine results in increased expression of CEBPA mRNA | CTD | PMID:31622651 |
Cebpa | Rat | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | multiple interactions | EXP | | 6480464 | 2 more ... | CTD | PMID:19414516 |
Cebpa | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in increased expression of CEBPA mRNA] | CTD | PMID:22206623 |
Cebpa | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CEBPA mRNA | CTD | PMID:22206623 |
Cebpa | Rat | 1-nitropyrene | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] and CEBPA protein inhibits the reaction [1-nitropyrene results in increased expression of ATG7 protein] | CTD | PMID:29078374 |
Cebpa | Rat | 1-nitropyrene | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | 1-nitropyrene results in decreased expression of CEBPA mRNA | CTD | PMID:29078374 |
Cebpa | Rat | 15-deoxy-Delta(12,14)-prostaglandin J2 | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | 15-deoxy-delta(12 and 14)-prostaglandin J2 results in increased expression of CEBPA mRNA | CTD | PMID:12021203 |
Cebpa | Rat | 17alpha-ethynylestradiol | decreases activity | EXP | | 6480464 | Ethinyl Estradiol results in decreased activity of CEBPA protein | CTD | PMID:12507762 |
Cebpa | Rat | 17beta-estradiol | affects expression | ISO | Cebpa (Mus musculus) | 6480464 | Estradiol affects the expression of CEBPA mRNA | CTD | PMID:15598610 |
Cebpa | Rat | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CEBPA mRNA | CTD | PMID:32145629 and PMID:35192832 |
Cebpa | Rat | 17beta-estradiol | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Estradiol results in increased expression of CEBPA mRNA | CTD | PMID:39298647 |
Cebpa | Rat | 17beta-estradiol | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of CEBPA mRNA | CTD | PMID:30165855 |
Cebpa | Rat | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of CEBPA mRNA | CTD | PMID:26164745 |
Cebpa | Rat | 17beta-estradiol | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Estradiol results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 |
Cebpa | Rat | 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Dihydrotestosterone results in decreased expression of CEBPA protein | CTD | PMID:18801408 |
Cebpa | Rat | 17beta-hydroxy-5alpha-androstan-3-one | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Dihydrotestosterone results in decreased expression of CEBPA mRNA and Dihydrotestosterone results in decreased expression of CEBPA protein | CTD | PMID:12960001 |
Cebpa | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:24559133 |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Cebpa (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA | CTD | PMID:24058054 |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA | CTD | PMID:28011154 |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 more ... |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA | CTD | PMID:15034205 more ... |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA | CTD | PMID:18796159 more ... |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CEBPA mRNA | CTD | PMID:22298810 |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] and Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter] | CTD | PMID:11133817 |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CEBPA mRNA and Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein | CTD | PMID:12758056 more ... |
Cebpa | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CEBPA protein] more ... | CTD | PMID:12758056 more ... |
Cebpa | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:30903904 |
Cebpa | Rat | 2-acetamidofluorene | decreases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in decreased expression of CEBPA protein | CTD | PMID:20188851 and PMID:21785164 |
Cebpa | Rat | 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein more ... | CTD | PMID:22107987 |
Cebpa | Rat | 2-amino-2-deoxy-D-glucopyranose 6-phosphate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | glucosamine 6-phosphate results in decreased expression of CEBPA protein | CTD | PMID:19427183 |
Cebpa | Rat | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | tetrabromobisphenol A results in increased expression of CEBPA mRNA | CTD | PMID:25863188 and PMID:30496566 |
Cebpa | Rat | 3,3',5-triiodo-L-thyronine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA more ... | CTD | PMID:33476690 |
Cebpa | Rat | 3,4-methylenedioxymethamphetamine | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of CEBPA mRNA | CTD | PMID:26251327 |
Cebpa | Rat | 3,4-methylenedioxymethamphetamine | affects methylation | ISO | Cebpa (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine affects the methylation of CEBPA promoter | CTD | PMID:26251327 |
Cebpa | Rat | 3,5,6-trichloro-2-pyridinol | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:32017950 |
Cebpa | Rat | 3,5,6-trichloropyridine-2-one | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 3 more ... | CTD | PMID:32017950 |
Cebpa | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... | CTD | PMID:11101056 more ... |
Cebpa | Rat | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Firemaster 550] results in increased expression of CEBPA mRNA more ... | CTD | PMID:23152186 more ... |
Cebpa | Rat | 3-methyladenine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] | CTD | PMID:29078374 |
Cebpa | Rat | 3-methylcholanthrene | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA | CTD | PMID:23519560 |
Cebpa | Rat | 3-phenylprop-2-enal | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | cinnamaldehyde results in decreased expression of CEBPA mRNA | CTD | PMID:21401097 |
Cebpa | Rat | 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1 and 2-dithiol-3-thione results in increased expression of CEBPA mRNA | CTD | PMID:19162173 |
Cebpa | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | bisphenol S results in increased expression of CEBPA mRNA | CTD | PMID:27003841 |
Cebpa | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CEBPA mRNA more ... | CTD | PMID:33865937 and PMID:35736896 |
Cebpa | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | bisphenol S results in increased expression of CEBPA mRNA | CTD | PMID:30951980 and PMID:30959087 |
Cebpa | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [bisphenol S co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA and [bisphenol S co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] affects the expression of CEBPA protein | CTD | PMID:27273607 and PMID:32220626 |
Cebpa | Rat | 4-hydroxynon-2-enal | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | 4-hydroxy-2-nonenal results in increased expression of CEBPA mRNA | CTD | PMID:19191707 |
Cebpa | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Fenretinide results in decreased expression of CEBPA mRNA | CTD | PMID:16467112 |
Cebpa | Rat | 4-tert-Octylphenol | decreases expression | EXP | | 6480464 | 4-tert-octylphenol results in decreased expression of CEBPA mRNA | CTD | PMID:26164745 |
Cebpa | Rat | 5-aza-2'-deoxycytidine | decreases methylation | ISO | CEBPA (Homo sapiens) | 6480464 | Decitabine results in decreased methylation of CEBPA promoter | CTD | PMID:19194470 |
Cebpa | Rat | 5-aza-2'-deoxycytidine | affects methylation | ISO | CEBPA (Homo sapiens) | 6480464 | Decitabine affects the methylation of CEBPA promoter | CTD | PMID:17510391 |
Cebpa | Rat | 5-azacytidine | decreases methylation | ISO | CEBPA (Homo sapiens) | 6480464 | Azacitidine results in decreased methylation of CEBPA promoter | CTD | PMID:19194470 |
Cebpa | Rat | 5-azacytidine | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Azacitidine results in increased expression of CEBPA mRNA | CTD | PMID:27590069 |
Cebpa | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of CEBPA mRNA | CTD | PMID:22504374 |
Cebpa | Rat | 9,10-epoxy-12-octadecenoic acid | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | 9 and 10-epoxy-12-octadecenoic acid results in increased expression of CEBPA mRNA | CTD | PMID:12021203 |
Cebpa | Rat | acrylamide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Acrylamide promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA mRNA] more ... | CTD | PMID:30409764 |
Cebpa | Rat | aflatoxin B1 | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CEBPA protein | CTD | PMID:20106945 |
Cebpa | Rat | aflatoxin B1 | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of CEBPA mRNA | CTD | PMID:27153756 and PMID:32234424 |
Cebpa | Rat | AICA ribonucleotide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | AICA ribonucleotide results in decreased expression of CEBPA protein | CTD | PMID:27103584 |
Cebpa | Rat | AICA ribonucleotide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] | CTD | PMID:27103584 |
Cebpa | Rat | alcohol | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Alcohols results in decreased expression of CEBPA protein | CTD | PMID:24025710 |
Cebpa | Rat | aldehydo-D-glucosamine 6-phosphate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | glucosamine 6-phosphate results in decreased expression of CEBPA protein | CTD | PMID:19427183 |
Cebpa | Rat | aldehydo-D-glucose | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... | CTD | PMID:24376792 |
Cebpa | Rat | all-trans-retinoic acid | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | PTK2 protein inhibits the reaction [Tretinoin promotes the reaction [CEBPA protein binds to RB1 protein]] more ... | CTD | PMID:16226872 more ... |
Cebpa | Rat | all-trans-retinoic acid | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CEBPA protein | CTD | PMID:34058077 |
Cebpa | Rat | all-trans-retinoic acid | increases activity | ISO | CEBPA (Homo sapiens) | 6480464 | Tretinoin results in increased activity of CEBPA protein | CTD | PMID:16226872 |
Cebpa | Rat | all-trans-retinoic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Tretinoin inhibits the reaction [CEBPA protein binds to RETN promoter] | CTD | PMID:15047602 |
Cebpa | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA | CTD | PMID:35163327 |
Cebpa | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of CEBPA mRNA | CTD | PMID:16483693 |
Cebpa | Rat | andrographolide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | andrographolide affects the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] affects the expression of CEBPA mRNA] and andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] | CTD | PMID:27475717 |
Cebpa | Rat | anthra[1,9-cd]pyrazol-6(2H)-one | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | pyrazolanthrone inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] | CTD | PMID:24376792 |
Cebpa | Rat | antimonite | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA | CTD | PMID:32076005 |
Cebpa | Rat | antimycin A | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Antimycin A results in increased expression of CEBPA mRNA | CTD | PMID:33512557 |
Cebpa | Rat | Aroclor 1254 | increases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of CEBPA mRNA | CTD | PMID:11163329 |
Cebpa | Rat | arsane | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Arsenic results in decreased expression of CEBPA mRNA and Arsenic results in decreased expression of CEBPA protein | CTD | PMID:23108036 |
Cebpa | Rat | arsane | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA and Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] | CTD | PMID:23108036 and PMID:32525701 |
Cebpa | Rat | arsenic atom | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA and Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein] | CTD | PMID:23108036 and PMID:32525701 |
Cebpa | Rat | arsenic atom | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Arsenic results in decreased expression of CEBPA mRNA and Arsenic results in decreased expression of CEBPA protein | CTD | PMID:23108036 |
Cebpa | Rat | arsenite(3-) | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | arsenite results in increased expression of CEBPA mRNA | CTD | PMID:15868481 |
Cebpa | Rat | arsenite(3-) | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CEBPA mRNA | CTD | PMID:32076005 |
Cebpa | Rat | arsenous acid | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of CEBPA protein | CTD | PMID:15916724 |
Cebpa | Rat | arsenous acid | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CEBPA mRNA and Arsenic Trioxide results in decreased expression of CEBPA protein | CTD | PMID:19662097 and PMID:21257625 |
Cebpa | Rat | arsenous acid | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CEBPA mRNA | CTD | PMID:20458559 |
Cebpa | Rat | avobenzone | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | avobenzone results in decreased expression of CEBPA mRNA | CTD | PMID:31016361 |
Cebpa | Rat | baicalein | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | baicalein results in decreased expression of CEBPA protein | CTD | PMID:24560969 |
Cebpa | Rat | benzamides | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Benzamides results in increased expression of CEBPA mRNA | CTD | PMID:28242381 |
Cebpa | Rat | benzene | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Benzene results in decreased expression of CEBPA mRNA | CTD | PMID:38866309 |
Cebpa | Rat | benzene | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | IGF2BP1 protein inhibits the reaction [Benzene results in decreased expression of CEBPA mRNA] | CTD | PMID:38866309 |
Cebpa | Rat | benzo[a]pyrene | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of CEBPA mRNA | CTD | PMID:22228805 |
Cebpa | Rat | benzo[a]pyrene | increases methylation | ISO | CEBPA (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of CEBPA exon | CTD | PMID:27901495 |
Cebpa | Rat | benzo[a]pyrene | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 more ... |
Cebpa | Rat | benzo[a]pyrene | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of CEBPA mRNA | CTD | PMID:15034205 |
Cebpa | Rat | benzo[a]pyrene | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CEBPA mRNA | CTD | PMID:21714911 |
Cebpa | Rat | benzo[a]pyrene diol epoxide I | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 |
Cebpa | Rat | benzofurans | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Benzofurans results in decreased expression of CEBPA mRNA and Benzofurans results in decreased expression of CEBPA protein | CTD | PMID:20863820 |
Cebpa | Rat | Benzyl parahydroxybenzoate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | benzylparaben results in increased expression of CEBPA mRNA | CTD | PMID:22956630 and PMID:27659731 |
Cebpa | Rat | berberine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA] more ... | CTD | PMID:20564506 |
Cebpa | Rat | berberine | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Berberine results in decreased expression of CEBPA mRNA and Berberine results in decreased expression of CEBPA protein | CTD | PMID:37511356 |
Cebpa | Rat | berberine | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Berberine results in decreased expression of CEBPA mRNA | CTD | PMID:26478571 |
Cebpa | Rat | beta-carotene | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | beta Carotene results in decreased expression of CEBPA mRNA | CTD | PMID:21569430 |
Cebpa | Rat | beta-D-glucosamine 6-sulfate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | glucosamine 6-O-sulfate results in decreased expression of CEBPA mRNA and glucosamine 6-O-sulfate results in decreased expression of CEBPA protein | CTD | PMID:19520133 |
Cebpa | Rat | beta-naphthoflavone | decreases expression | EXP | | 6480464 | beta-Naphthoflavone results in decreased expression of CEBPA mRNA and beta-Naphthoflavone results in decreased expression of CEBPA protein | CTD | PMID:19389873 |
Cebpa | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of CEBPA mRNA | CTD | PMID:19245819 |
Cebpa | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA | CTD | PMID:37021957 |
Cebpa | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of CEBPA mRNA | CTD | PMID:31163220 |
Cebpa | Rat | bismuth atom | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA | CTD | PMID:34560244 |
Cebpa | Rat | bismuthane | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA | CTD | PMID:34560244 |
Cebpa | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CEBPA mRNA | CTD | PMID:20019905 more ... |
Cebpa | Rat | bisphenol A | increases methylation | ISO | CEBPA (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of CEBPA gene | CTD | PMID:31601247 |
Cebpa | Rat | bisphenol A | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CEBPA mRNA more ... | CTD | PMID:31601247 more ... |
Cebpa | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | lithospermate B inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA] | CTD | PMID:34165232 |
Cebpa | Rat | bisphenol A | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | bisphenol A analog results in decreased expression of CEBPA mRNA and bisphenol A results in decreased expression of CEBPA mRNA | CTD | PMID:32387340 |
Cebpa | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of CEBPA gene | CTD | PMID:28505145 |
Cebpa | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of CEBPA mRNA | CTD | PMID:25181051 more ... |
Cebpa | Rat | bisphenol A | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CEBPA mRNA and bisphenol A results in increased expression of CEBPA protein | CTD | PMID:24418828 more ... |
Cebpa | Rat | bisphenol A | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | bisphenol A results in decreased expression of CEBPA mRNA and bisphenol A results in decreased expression of CEBPA protein | CTD | PMID:26146954 and PMID:30133442 |
Cebpa | Rat | bisphenol A | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | bisphenol A results in increased expression of CEBPA more ... | CTD | PMID:26942597 more ... |
Cebpa | Rat | bisphenol A | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of CEBPA protein more ... | CTD | PMID:26820058 more ... |
Cebpa | Rat | Bisphenol A diglycidyl ether | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | bisphenol A diglycidyl ether inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] | CTD | PMID:22956630 |
Cebpa | Rat | Bisphenol A diglycidyl ether | multiple interactions | EXP | | 6480464 | bisphenol A diglycidyl ether inhibits the reaction [TRIB3 protein affects the expression of CEBPA protein] | CTD | PMID:21190014 |
Cebpa | Rat | Bisphenol B | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | bisphenol B results in decreased expression of CEBPA mRNA | CTD | PMID:32387340 |
Cebpa | Rat | bisphenol F | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | bisphenol F results in increased expression of CEBPA mRNA | CTD | PMID:30951980 |
Cebpa | Rat | bisphenol F | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of CEBPA mRNA more ... | CTD | PMID:33865937 and PMID:35736896 |
Cebpa | Rat | boric acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA] more ... | CTD | PMID:28285642 |
Cebpa | Rat | bortezomib | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | Bortezomib inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] | CTD | PMID:19662097 |
Cebpa | Rat | Butylbenzyl phthalate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of CEBPA mRNA more ... | CTD | PMID:26820058 more ... |
Cebpa | Rat | Butylparaben | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] more ... | CTD | PMID:22956630 more ... |
Cebpa | Rat | Butylparaben | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | butylparaben results in increased expression of CEBPA mRNA | CTD | PMID:22956630 more ... |
Cebpa | Rat | Butylparaben | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | butylparaben results in increased expression of CEBPA mRNA | CTD | PMID:22956630 |
Cebpa | Rat | C60 fullerene | increases expression | EXP | | 6480464 | fullerene C60 results in increased expression of CEBPA mRNA | CTD | PMID:19167457 |
Cebpa | Rat | cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of CEBPA mRNA | CTD | PMID:17327700 |
Cebpa | Rat | cadmium atom | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA | CTD | PMID:35301059 |
Cebpa | Rat | cadmium atom | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA | CTD | PMID:29939372 |
Cebpa | Rat | cadmium atom | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Cadmium results in decreased expression of CEBPA protein | CTD | PMID:21848503 |
Cebpa | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CEBPA mRNA | CTD | PMID:17327700 |
Cebpa | Rat | cadmium dichloride | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA | CTD | PMID:35301059 |
Cebpa | Rat | cadmium dichloride | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of CEBPA mRNA | CTD | PMID:38382870 |
Cebpa | Rat | cadmium dichloride | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CEBPA mRNA more ... | CTD | PMID:23921151 and PMID:29939372 |
Cebpa | Rat | cadmium dichloride | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of CEBPA mRNA | CTD | PMID:12160620 |
Cebpa | Rat | caffeine | decreases expression | EXP | | 6480464 | Caffeine results in decreased expression of CEBPA mRNA | CTD | PMID:23727198 |
Cebpa | Rat | caffeine | increases expression | EXP | | 6480464 | Caffeine results in increased expression of CEBPA mRNA | CTD | PMID:30423288 and PMID:30776459 |
Cebpa | Rat | caffeine | affects expression | EXP | | 6480464 | Caffeine affects the expression of CEBPA mRNA | CTD | PMID:30528684 |
Cebpa | Rat | calcitriol | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Calcitriol results in decreased expression of CEBPA mRNA | CTD | PMID:16368784 |
Cebpa | Rat | calcium dichloride | increases activity | ISO | CEBPA (Homo sapiens) | 6480464 | Calcium Chloride results in increased activity of CEBPA protein | CTD | PMID:17214633 |
Cebpa | Rat | cannabidiolic acid | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | cannabidiolic acid results in increased expression of CEBPA mRNA | CTD | PMID:30611848 |
Cebpa | Rat | cannabidiolic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | cannabidiolic acid promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] | CTD | PMID:30611848 |
Cebpa | Rat | capsaicin | multiple interactions | EXP | | 6480464 | Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] | CTD | PMID:20359164 |
Cebpa | Rat | capsaicin | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Capsaicin results in decreased expression of CEBPA protein | CTD | PMID:17295509 |
Cebpa | Rat | carbaryl | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Carbaryl results in decreased expression of CEBPA mRNA | CTD | PMID:27829164 |
Cebpa | Rat | carbon nanotube | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25620056 |
Cebpa | Rat | celastrol | affects expression | ISO | Cebpa (Mus musculus) | 6480464 | celastrol affects the expression of CEBPA mRNA and celastrol affects the expression of CEBPA protein | CTD | PMID:27085773 |
Cebpa | Rat | celecoxib | multiple interactions | EXP | | 6480464 | Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] | CTD | PMID:19247274 |
Cebpa | Rat | cerulenin | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Cerulenin results in decreased expression of CEBPA mRNA | CTD | PMID:15707987 |
Cebpa | Rat | ceruletide | multiple interactions | EXP | | 6480464 | [Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPA protein more ... | CTD | PMID:26873426 |
Cebpa | Rat | ceruletide | increases expression | EXP | | 6480464 | Ceruletide results in increased expression of CEBPA mRNA | CTD | PMID:26873426 |
Cebpa | Rat | CGP 52608 | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CEBPA gene] | CTD | PMID:28238834 |
Cebpa | Rat | chlorpyrifos | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA] and Chlorpyrifos promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein] | CTD | PMID:32017950 |
Cebpa | Rat | chlorpyrifos | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CEBPA mRNA | CTD | PMID:37019170 |
Cebpa | Rat | cholesterol | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [[artemisic acid results in decreased expression of CEBPA mRNA] which results in decreased expression of HMGCR mRNA] which results in decreased chemical synthesis of Cholesterol | CTD | PMID:23063590 |
Cebpa | Rat | choline | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... | CTD | PMID:20938992 and PMID:25712622 |
Cebpa | Rat | choline | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA] and [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA | CTD | PMID:25712622 |
Cebpa | Rat | chrysin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | chrysin results in increased expression of CEBPA protein | CTD | PMID:30445784 |
Cebpa | Rat | cisplatin | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of CEBPA mRNA | CTD | PMID:27392435 |
Cebpa | Rat | clofazimine | increases expression | EXP | | 6480464 | Clofazimine results in increased expression of CEBPA protein | CTD | PMID:31393584 |
Cebpa | Rat | Clofop | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [fenofibric acid binds to PPARA protein] which results in increased expression of CEBPA mRNA | CTD | PMID:16197558 |
Cebpa | Rat | clozapine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA mRNA] and Berberine inhibits the reaction [Clozapine results in increased expression of CEBPA protein] | CTD | PMID:20564506 |
Cebpa | Rat | clozapine | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Clozapine results in increased expression of CEBPA mRNA and Clozapine results in increased expression of CEBPA protein | CTD | PMID:20564506 |
Cebpa | Rat | cobalt dichloride | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | cobaltous chloride results in decreased expression of CEBPA mRNA | CTD | PMID:20594416 |
Cebpa | Rat | colforsin daropate hydrochloride | increases expression | EXP | | 6480464 | Colforsin results in increased expression of CEBPA protein | CTD | PMID:21832167 |
Cebpa | Rat | colforsin daropate hydrochloride | multiple interactions | EXP | | 6480464 | Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] | CTD | PMID:21832167 |
Cebpa | Rat | colforsin daropate hydrochloride | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Colforsin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA] | CTD | PMID:17407152 |
Cebpa | Rat | copper(II) sulfate | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CEBPA mRNA | CTD | PMID:19549813 |
Cebpa | Rat | cordycepin | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | cordycepin inhibits the reaction [[Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] | CTD | PMID:34575692 |
Cebpa | Rat | corticosterone | increases expression | EXP | | 6480464 | Corticosterone results in increased expression of CEBPA mRNA | CTD | PMID:30423288 |
Cebpa | Rat | cortisol | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA more ... | CTD | PMID:30528684 more ... |
Cebpa | Rat | cortisol | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Hydrocortisone results in increased expression of CEBPA mRNA and Hydrocortisone results in increased expression of CEBPA protein | CTD | PMID:30528684 more ... |
Cebpa | Rat | cucurbitacin B | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | cucurbitacin B results in decreased expression of CEBPA mRNA | CTD | PMID:24316209 |
Cebpa | Rat | cucurbitacin B | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of CEBPA mRNA] | CTD | PMID:24316209 |
Cebpa | Rat | cucurbitacin I | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | cucurbitacin I results in decreased expression of CEBPA mRNA | CTD | PMID:24316209 |
Cebpa | Rat | curcumin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] more ... | CTD | PMID:19297423 and PMID:28595985 |
Cebpa | Rat | cyclosporin A | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of CEBPA mRNA | CTD | PMID:20106945 more ... |
Cebpa | Rat | D-glucose | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... | CTD | PMID:24376792 |
Cebpa | Rat | DDE | decreases activity | ISO | CEBPA (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased activity of CEBPA protein | CTD | PMID:27589886 |
Cebpa | Rat | DDT | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | DDT results in increased activity of and results in increased localization of CEBPA protein | CTD | PMID:11911853 |
Cebpa | Rat | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of CEBPA mRNA | CTD | PMID:23914054 |
Cebpa | Rat | deguelin | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | [deguelin results in decreased expression of NPM1 protein mutant form] which results in decreased expression of CEBPA protein | CTD | PMID:25242579 |
Cebpa | Rat | deoxynivalenol | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA | CTD | PMID:28865950 |
Cebpa | Rat | deoxynivalenol | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of CEBPA mRNA | CTD | PMID:28935499 |
Cebpa | Rat | dexamethasone | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... | CTD | PMID:11101056 more ... |
Cebpa | Rat | dexamethasone | multiple interactions | EXP | | 6480464 | [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] | CTD | PMID:32494933 |
Cebpa | Rat | dexamethasone | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Dexamethasone results in increased expression of CEBPA mRNA | CTD | PMID:22956630 and PMID:25068083 |
Cebpa | Rat | dexamethasone | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Dexamethasone results in increased expression of CEBPA mRNA | CTD | PMID:24418828 and PMID:27003841 |
Cebpa | Rat | dexamethasone | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA more ... | CTD | PMID:23152186 more ... |
Cebpa | Rat | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CEBPA mRNA and Dexamethasone results in increased expression of CEBPA protein | CTD | PMID:12837037 more ... |
Cebpa | Rat | diallyl trisulfide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | diallyl trisulfide results in decreased expression of CEBPA mRNA and diallyl trisulfide results in decreased expression of CEBPA protein | CTD | PMID:22137902 |
Cebpa | Rat | diallyl trisulfide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN more ... | CTD | PMID:22137902 |
Cebpa | Rat | diarsenic trioxide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of CEBPA protein | CTD | PMID:15916724 |
Cebpa | Rat | diarsenic trioxide | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Arsenic Trioxide results in decreased expression of CEBPA mRNA and Arsenic Trioxide results in decreased expression of CEBPA protein | CTD | PMID:19662097 and PMID:21257625 |
Cebpa | Rat | diarsenic trioxide | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of CEBPA mRNA | CTD | PMID:20458559 |
Cebpa | Rat | diazinon | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Diazinon results in increased expression of CEBPA protein | CTD | PMID:33872936 |
Cebpa | Rat | diazinon | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Fulvestrant inhibits the reaction [Diazinon results in increased expression of CEBPA protein] | CTD | PMID:33872936 |
Cebpa | Rat | Dibutyl phosphate | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of CEBPA mRNA | CTD | PMID:37042841 |
Cebpa | Rat | dibutyl phthalate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of CEBPA mRNA | CTD | PMID:17361019 and PMID:21266533 |
Cebpa | Rat | dibutyl phthalate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA | CTD | PMID:37021957 |
Cebpa | Rat | dibutylstannane | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | di-n-butyltin results in increased expression of CEBPA mRNA | CTD | PMID:29787037 |
Cebpa | Rat | dibutylstannane | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | T 0070907 inhibits the reaction [di-n-butyltin results in increased expression of CEBPA mRNA] | CTD | PMID:29787037 |
Cebpa | Rat | diethyl phthalate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA | CTD | PMID:37021957 |
Cebpa | Rat | diethylstilbestrol | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Diethylstilbestrol results in increased expression of CEBPA mRNA and Diethylstilbestrol results in increased expression of CEBPA protein | CTD | PMID:22710028 |
Cebpa | Rat | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of CEBPA mRNA | CTD | PMID:37077353 |
Cebpa | Rat | diethylstilbestrol | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of CEBPA protein] | CTD | PMID:22710028 |
Cebpa | Rat | diisobutyl phthalate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA | CTD | PMID:37021957 |
Cebpa | Rat | diisononyl phthalate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [diethyl phthalate co-treated with Dibutyl Phthalate co-treated with diisobutyl phthalate co-treated with Diethylhexyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisononyl phthalate] results in increased expression of CEBPA mRNA | CTD | PMID:37021957 |
Cebpa | Rat | diisononyl phthalate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | diisononyl phthalate results in increased expression of CEBPA mRNA | CTD | PMID:31546122 and PMID:37927243 |
Cebpa | Rat | dioxygen | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Oxygen deficiency results in decreased expression of CEBPA mRNA | CTD | PMID:20594416 |
Cebpa | Rat | dioxygen | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CEBPA mRNA | CTD | PMID:30529165 |
Cebpa | Rat | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Antimony Potassium Tartrate results in increased abundance of antimonite] which results in decreased expression of CEBPA mRNA | CTD | PMID:32076005 |
Cebpa | Rat | diquat | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Diquat results in increased expression of CEBPA mRNA | CTD | PMID:36851058 |
Cebpa | Rat | doxorubicin | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CEBPA protein | CTD | PMID:19662097 |
Cebpa | Rat | duvoglustat | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 1-Deoxynojirimycin inhibits the reaction [Dietary Fats results in increased expression of CEBPA mRNA] | CTD | PMID:25445511 |
Cebpa | Rat | efavirenz | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | efavirenz results in decreased expression of CEBPA mRNA | CTD | PMID:21619898 |
Cebpa | Rat | elemental selenium | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Selenium results in increased expression of CEBPA mRNA | CTD | PMID:28810182 |
Cebpa | Rat | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of CEBPA mRNA | CTD | PMID:29391264 |
Cebpa | Rat | endrin | decreases activity | ISO | Cebpa (Mus musculus) | 6480464 | Endrin results in decreased activity of CEBPA protein | CTD | PMID:10385688 |
Cebpa | Rat | endrin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Endrin results in increased expression of CEBPA mRNA | CTD | PMID:34801515 |
Cebpa | Rat | endrin | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Endrin results in decreased expression of CEBPA protein | CTD | PMID:10385688 |
Cebpa | Rat | enzalutamide | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | enzalutamide affects the expression of CEBPA mRNA | CTD | PMID:30940724 |
Cebpa | Rat | epoxiconazole | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | epoxiconazole results in increased expression of CEBPA mRNA | CTD | PMID:35436446 |
Cebpa | Rat | epoxomicin | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | epoxomicin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] | CTD | PMID:19662097 |
Cebpa | Rat | ethanol | decreases activity | ISO | Cebpa (Mus musculus) | 6480464 | Ethanol results in decreased activity of CEBPA protein | CTD | PMID:16737972 |
Cebpa | Rat | ethanol | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Ethanol results in increased expression of CEBPA mRNA | CTD | PMID:35713687 |
Cebpa | Rat | ethanol | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | HECTD4 protein promotes the reaction [Ethanol results in increased expression of CEBPA mRNA] | CTD | PMID:35713687 |
Cebpa | Rat | ethanol | affects expression | ISO | Cebpa (Mus musculus) | 6480464 | Ethanol affects the expression of CEBPA mRNA | CTD | PMID:30319688 |
Cebpa | Rat | ethanol | affects expression | EXP | | 6480464 | Ethanol affects the expression of CEBPA mRNA | CTD | PMID:31039417 |
Cebpa | Rat | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of CEBPA mRNA | CTD | PMID:26188107 more ... |
Cebpa | Rat | ethanol | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Ethanol results in decreased expression of CEBPA protein | CTD | PMID:16737972 |
Cebpa | Rat | ethanol | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein] and Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] | CTD | PMID:16737972 |
Cebpa | Rat | ethanol | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Ethanol results in decreased expression of CEBPA protein | CTD | PMID:16737972 |
Cebpa | Rat | ethylparaben | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | ethyl-p-hydroxybenzoate results in increased expression of CEBPA mRNA | CTD | PMID:22956630 |
Cebpa | Rat | etoposide | increases degradation | ISO | CEBPA (Homo sapiens) | 6480464 | Etoposide results in increased degradation of CEBPA protein | CTD | PMID:19662097 |
Cebpa | Rat | etoposide | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Etoposide results in decreased expression of CEBPA mRNA and Etoposide results in decreased expression of CEBPA protein | CTD | PMID:19662097 |
Cebpa | Rat | fenthion | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Fenthion results in increased expression of CEBPA mRNA | CTD | PMID:34813904 |
Cebpa | Rat | fipronil | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] | CTD | PMID:27103584 |
Cebpa | Rat | fipronil | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | fipronil results in increased expression of CEBPA mRNA and fipronil results in increased expression of CEBPA protein | CTD | PMID:27103584 |
Cebpa | Rat | flavonoids | decreases expression | EXP | | 6480464 | Flavonoids results in decreased expression of CEBPA mRNA | CTD | PMID:23238999 |
Cebpa | Rat | folic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... | CTD | PMID:20938992 and PMID:22206623 |
Cebpa | Rat | fulvestrant | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of CEBPA gene | CTD | PMID:31601247 |
Cebpa | Rat | fulvestrant | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Fulvestrant inhibits the reaction [Diazinon results in increased expression of CEBPA protein] more ... | CTD | PMID:33872936 |
Cebpa | Rat | genistein | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Genistein results in decreased expression of CEBPA mRNA | CTD | PMID:21048042 |
Cebpa | Rat | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of CEBPA mRNA | CTD | PMID:24361872 |
Cebpa | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CEBPA mRNA | CTD | PMID:33387578 |
Cebpa | Rat | Geraniin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | STO 609 inhibits the reaction [Geraniin results in increased expression of CEBPA protein] | CTD | PMID:36706894 |
Cebpa | Rat | Geraniin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Geraniin results in increased expression of CEBPA protein | CTD | PMID:36706894 |
Cebpa | Rat | Gingerenone A | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | gingerenone A inhibits the reaction [INS protein results in increased expression of CEBPA protein] | CTD | PMID:28556482 |
Cebpa | Rat | gingerol | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | gingerol results in decreased expression of CEBPA mRNA and gingerol results in decreased expression of CEBPA protein | CTD | PMID:26498061 |
Cebpa | Rat | gingerol | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA mRNA] and GSK3B protein promotes the reaction [gingerol results in decreased expression of CEBPA protein] | CTD | PMID:26498061 |
Cebpa | Rat | glucose | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein affects the reaction [Glucose results in increased expression of and results in increased secretion of EDN1 protein] more ... | CTD | PMID:24376792 |
Cebpa | Rat | glycerol 2-phosphate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein | CTD | PMID:14505802 |
Cebpa | Rat | glycerol 2-phosphate | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA | CTD | PMID:25932594 |
Cebpa | Rat | glycyrrhizinic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Glycyrrhizic Acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA mRNA] | CTD | PMID:34302803 |
Cebpa | Rat | GW 501516 | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [GW 501516 binds to PPARD protein] which results in increased expression of CEBPA mRNA | CTD | PMID:16197558 |
Cebpa | Rat | hemin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | HAMP mRNA promotes the reaction [Hemin results in increased expression of CEBPA mRNA] | CTD | PMID:29749404 |
Cebpa | Rat | hemin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Hemin results in increased expression of CEBPA mRNA | CTD | PMID:29749404 |
Cebpa | Rat | herbimycin | multiple interactions | EXP | | 6480464 | herbimycin inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of [[CEBPA protein binds to CEBPB protein] which binds to PTGS2 promoter]] | CTD | PMID:11133817 |
Cebpa | Rat | hesperetin | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | hesperetin results in decreased expression of CEBPA protein | CTD | PMID:25345581 |
Cebpa | Rat | hexadecanoic acid | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA more ... | CTD | PMID:26873426 |
Cebpa | Rat | hexadecanoic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Palmitic Acid co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA more ... | CTD | PMID:34968464 |
Cebpa | Rat | hispidulin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | hispidulin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA] | CTD | PMID:30055130 |
Cebpa | Rat | hydrazines | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Hydrazines results in decreased expression of CEBPA mRNA | CTD | PMID:21647536 |
Cebpa | Rat | hydrogen peroxide | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of CEBPA mRNA | CTD | PMID:23410634 |
Cebpa | Rat | hydroxytyrosol | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | 3 and 4-dihydroxyphenylethanol results in decreased expression of CEBPA mRNA | CTD | PMID:21569430 |
Cebpa | Rat | indirubin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPA protein] and [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPA protein] | CTD | PMID:18344322 |
Cebpa | Rat | indometacin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein co-treated with Indomethacin] results in increased expression of CEBPA mRNA more ... | CTD | PMID:22107987 more ... |
Cebpa | Rat | indometacin | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Bismuth affects the susceptibility to [INS protein co-treated with Dexamethasone co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine]] which results in decreased expression of CEBPA mRNA more ... | CTD | PMID:28628672 more ... |
Cebpa | Rat | insulin | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA and cordycepin inhibits the reaction [[Dexamethasone co-treated with Insulin co-treated with Indomethacin co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of CEBPA mRNA] | CTD | PMID:34575692 |
Cebpa | Rat | isoliquiritigenin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] | CTD | PMID:27117918 |
Cebpa | Rat | isoniazide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Isoniazid results in decreased expression of CEBPA mRNA and Isoniazid results in decreased expression of CEBPA protein | CTD | PMID:24128855 |
Cebpa | Rat | ivermectin | affects expression | ISO | Cebpa (Mus musculus) | 6480464 | Ivermectin affects the expression of CEBPA mRNA | CTD | PMID:31199990 |
Cebpa | Rat | ivermectin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Ivermectin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] and Rosiglitazone affects the reaction [Ivermectin affects the expression of CEBPA mRNA] | CTD | PMID:31199990 |
Cebpa | Rat | ketoconazole | increases expression | EXP | | 6480464 | Ketoconazole results in increased expression of CEBPA mRNA | CTD | PMID:37077353 |
Cebpa | Rat | L-ascorbic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of CEBPA protein | CTD | PMID:14505802 |
Cebpa | Rat | L-ascorbic acid | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of CEBPA mRNA | CTD | PMID:25932594 |
Cebpa | Rat | L-methionine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CEBPA gene more ... | CTD | PMID:20938992 and PMID:25712622 |
Cebpa | Rat | L-methionine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA] and [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA | CTD | PMID:25712622 |
Cebpa | Rat | lactucin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | lactucin affects the reaction [Dietary Fats affects the expression of CEBPA mRNA] and lactucin affects the reaction [Dietary Fats affects the expression of CEBPA protein] | CTD | PMID:32023857 |
Cebpa | Rat | lead diacetate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | lead acetate results in increased expression of CEBPA mRNA | CTD | PMID:20542052 |
Cebpa | Rat | lead diacetate | increases methylation | EXP | | 6480464 | lead acetate results in increased methylation of CEBPA gene | CTD | PMID:29571894 |
Cebpa | Rat | lead diacetate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | lead acetate results in decreased expression of CEBPA mRNA | CTD | PMID:21829687 |
Cebpa | Rat | lead(0) | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Lead results in increased expression of CEBPA | CTD | PMID:23086611 |
Cebpa | Rat | lipopolysaccharide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein more ... | CTD | PMID:22107987 |
Cebpa | Rat | lipopolysaccharide | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of CEBPA mRNA | CTD | PMID:35811015 |
Cebpa | Rat | lipopolysaccharide | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEBPA mRNA | CTD | PMID:35811015 |
Cebpa | Rat | lipopolysaccharide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of CEBPA mRNA | CTD | PMID:26582142 |
Cebpa | Rat | lithium chloride | multiple interactions | EXP | | 6480464 | [Lithium Chloride co-treated with Pilocarpine] affects the reaction [Dexamethasone results in increased expression of CEBPA mRNA] | CTD | PMID:32494933 |
Cebpa | Rat | loliolide | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | loliolide results in decreased expression of CEBPA protein | CTD | PMID:33567534 |
Cebpa | Rat | LY294002 | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of CEBPA mRNA] | CTD | PMID:25712622 |
Cebpa | Rat | menadione | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of CEBPA mRNA | CTD | PMID:20044591 and PMID:23410634 |
Cebpa | Rat | mercury dichloride | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Mercuric Chloride results in decreased expression of CEBPA mRNA | CTD | PMID:11267658 |
Cebpa | Rat | mercury dichloride | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Mercuric Chloride results in decreased expression of and results in decreased activity of CEBPA protein | CTD | PMID:11267658 |
Cebpa | Rat | metformin | decreases expression | EXP | | 6480464 | Metformin results in decreased expression of CEBPA mRNA | CTD | PMID:19022234 |
Cebpa | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of CEBPA mRNA | CTD | PMID:22504374 |
Cebpa | Rat | methoxychlor | decreases expression | EXP | | 6480464 | Methoxychlor results in decreased expression of CEBPA mRNA | CTD | PMID:23303685 |
Cebpa | Rat | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of CEBPA gene | CTD | PMID:35440735 |
Cebpa | Rat | methylparaben | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | methylparaben results in increased expression of CEBPA mRNA | CTD | PMID:28527915 |
Cebpa | Rat | mifepristone | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Mifepristone inhibits the reaction [bisphenol A results in increased expression of CEBPA mRNA] and Mifepristone inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] | CTD | PMID:22956630 and PMID:27145005 |
Cebpa | Rat | mifepristone | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | Mifepristone inhibits the reaction [Hydrocortisone results in increased expression of CEBPA mRNA] | CTD | PMID:30528684 |
Cebpa | Rat | MK-2206 | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | MK 2206 inhibits the reaction [RARRES2 protein results in increased expression of CEBPA protein] | CTD | PMID:34398343 |
Cebpa | Rat | MK-2206 | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | MK 2206 results in decreased expression of CEBPA protein | CTD | PMID:34398343 |
Cebpa | Rat | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein | CTD | PMID:21832167 |
Cebpa | Rat | mono(2-ethylhexyl) phthalate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of CEBPA mRNA | CTD | PMID:25543134 and PMID:27384973 |
Cebpa | Rat | mono(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein | CTD | PMID:21832167 |
Cebpa | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | EXP | | 6480464 | Colforsin inhibits the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of CEBPA protein] | CTD | PMID:21832167 |
Cebpa | Rat | N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CEBPA mRNA] | CTD | PMID:17407152 |
Cebpa | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of CEBPA protein] | CTD | PMID:27117918 |
Cebpa | Rat | N-acetyl-L-cysteine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of CEBPA protein] | CTD | PMID:35622622 |
Cebpa | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | increases ubiquitination | ISO | CEBPA (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of CEBPA protein | CTD | PMID:19662097 |
Cebpa | Rat | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] | CTD | PMID:19662097 |
Cebpa | Rat | N-nitrosodiethylamine | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Diethylnitrosamine results in decreased expression of CEBPA mRNA | CTD | PMID:21527772 |
Cebpa | Rat | N-nitrosodiethylamine | decreases expression | EXP | | 6480464 | Diethylnitrosamine results in decreased expression of CEBPA mRNA | CTD | PMID:19638242 |
Cebpa | Rat | N-Nitrosopyrrolidine | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | N-Nitrosopyrrolidine results in decreased expression of CEBPA mRNA | CTD | PMID:32234424 |
Cebpa | Rat | nevirapine | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Nevirapine results in increased expression of CEBPA mRNA | CTD | PMID:21619898 |
Cebpa | Rat | nicotine | multiple interactions | EXP | | 6480464 | [Nicotine results in increased abundance of Cotinine] which results in increased expression of CEBPA protein | CTD | PMID:29617909 |
Cebpa | Rat | nicotine | affects expression | EXP | | 6480464 | Nicotine affects the expression of CEBPA mRNA | CTD | PMID:31972234 |
Cebpa | Rat | nicotine | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Nicotine results in increased expression of CEBPA mRNA | CTD | PMID:31622651 |
Cebpa | Rat | nicotinic acid | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Niacin results in increased expression of CEBPA mRNA | CTD | PMID:19131065 |
Cebpa | Rat | nimesulide | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | nimesulide promotes the reaction [[Galactosamine co-treated with Lipopolysaccharides] results in decreased expression of CEBPA protein] | CTD | PMID:22107987 |
Cebpa | Rat | nimesulide | multiple interactions | EXP | | 6480464 | nimesulide inhibits the reaction [Dietary Fats results in decreased expression of CEBPA mRNA] | CTD | PMID:19247274 |
Cebpa | Rat | norwogonin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | norwogonin analog results in increased expression of CEBPA protein and norwogonin results in increased expression of CEBPA protein | CTD | PMID:30445784 |
Cebpa | Rat | ochratoxin A | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | ochratoxin A results in decreased expression of CEBPA | CTD | PMID:20590410 |
Cebpa | Rat | orlistat | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | Orlistat promotes the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein] | CTD | PMID:33476690 |
Cebpa | Rat | osthole | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | osthol results in increased expression of CEBPA mRNA | CTD | PMID:19682441 |
Cebpa | Rat | p-tert-Amylphenol | decreases expression | EXP | | 6480464 | 4-tert-octylphenol results in decreased expression of CEBPA mRNA | CTD | PMID:26164745 |
Cebpa | Rat | paracetamol | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Acetaminophen results in decreased expression of CEBPA mRNA | CTD | PMID:29246445 |
Cebpa | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of CEBPA mRNA | CTD | PMID:33387578 |
Cebpa | Rat | paracetamol | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in decreased expression of CEBPA mRNA] | CTD | PMID:29246445 |
Cebpa | Rat | paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of CEBPA mRNA | CTD | PMID:32680482 |
Cebpa | Rat | perfluorobutanesulfonic acid | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | perfluorobutanesulfonic acid results in increased expression of CEBPA mRNA and perfluorobutanesulfonic acid results in increased expression of CEBPA protein | CTD | PMID:30031040 |
Cebpa | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | perfluorooctane sulfonic acid results in increased expression of CEBPA mRNA | CTD | PMID:26548598 |
Cebpa | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CEBPA mRNA | CTD | PMID:36331819 |
Cebpa | Rat | perfluorooctane-1-sulfonic acid | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid affects the expression of CEBPA mRNA | CTD | PMID:30738844 |
Cebpa | Rat | perfluorooctane-1-sulfonic acid | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in increased expression of CEBPA mRNA | CTD | PMID:26548598 |
Cebpa | Rat | perfluorooctanoic acid | increases activity | ISO | CEBPA (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased activity of CEBPA protein | CTD | PMID:27589886 |
Cebpa | Rat | perfluorooctanoic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [[Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA] and [Dexamethasone co-treated with INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA | CTD | PMID:29094436 |
Cebpa | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of CEBPA mRNA | CTD | PMID:35163327 |
Cebpa | Rat | permethrin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Permethrin results in increased expression of CEBPA mRNA | CTD | PMID:24911977 |
Cebpa | Rat | Phenylamil | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | phenylamil results in increased expression of CEBPA mRNA | CTD | PMID:20519739 |
Cebpa | Rat | phenylephrine | decreases expression | EXP | | 6480464 | Phenylephrine results in decreased expression of CEBPA mRNA | CTD | PMID:19443575 |
Cebpa | Rat | phorbol 13-acetate 12-myristate | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CEBPA mRNA | CTD | PMID:23519560 |
Cebpa | Rat | phoxim | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | phoxim results in increased expression of CEBPA protein | CTD | PMID:33872936 |
Cebpa | Rat | phoxim | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Fulvestrant inhibits the reaction [phoxim results in increased expression of CEBPA protein] | CTD | PMID:33872936 |
Cebpa | Rat | pioglitazone | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | pioglitazone results in increased expression of CEBPA mRNA | CTD | PMID:28242381 |
Cebpa | Rat | pirinixic acid | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [pirinixic acid co-treated with PPARA] results in decreased expression of CEBPA mRNA | CTD | PMID:20813756 |
Cebpa | Rat | pirinixic acid | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of CEBPA mRNA | CTD | PMID:18445702 more ... |
Cebpa | Rat | pirinixic acid | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CEBPA mRNA | CTD | PMID:19710929 |
Cebpa | Rat | platycodin D | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | CTNNB1 affects the reaction [platycodin D results in decreased expression of CEBPA protein] | CTD | PMID:21798269 |
Cebpa | Rat | platycodin D | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | platycodin D results in decreased expression of CEBPA protein | CTD | PMID:30599906 |
Cebpa | Rat | platycodin D | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | platycodin D results in decreased expression of CEBPA mRNA and platycodin D results in decreased expression of CEBPA protein | CTD | PMID:21798269 more ... |
Cebpa | Rat | pomalidomide | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | pomalidomide results in increased expression of CEBPA mRNA | CTD | PMID:15292067 |
Cebpa | Rat | prednisone | affects expression | ISO | Cebpa (Mus musculus) | 6480464 | Prednisone affects the expression of CEBPA mRNA | CTD | PMID:38439560 |
Cebpa | Rat | prednisone | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Prednisone results in decreased expression of CEBPA protein | CTD | PMID:38439560 |
Cebpa | Rat | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of CEBPA mRNA | CTD | PMID:28903501 |
Cebpa | Rat | propiconazole | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | propiconazole results in decreased expression of CEBPA mRNA | CTD | PMID:21278054 |
Cebpa | Rat | propylparaben | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | propylparaben results in increased expression of CEBPA mRNA | CTD | PMID:22956630 |
Cebpa | Rat | prostaglandin E2 | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein]] | CTD | PMID:25432964 |
Cebpa | Rat | quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [[Dietary Fats co-treated with Ceruletide] results in increased expression of CEBPA protein] more ... | CTD | PMID:26873426 |
Cebpa | Rat | quercetin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of CEBPA protein] more ... | CTD | PMID:18586010 more ... |
Cebpa | Rat | quercetin | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CEBPA mRNA | CTD | PMID:21632981 |
Cebpa | Rat | raloxifene | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | IWR-1 compound inhibits the reaction [Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein]] and Raloxifene Hydrochloride inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] | CTD | PMID:31470850 |
Cebpa | Rat | raloxifene | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Raloxifene Hydrochloride results in decreased expression of CEBPA mRNA | CTD | PMID:15849065 |
Cebpa | Rat | reactive oxygen species | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Reactive Oxygen Species results in decreased expression of CEBPA mRNA | CTD | PMID:25800948 |
Cebpa | Rat | resveratrol | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | resveratrol metabolite results in decreased expression of CEBPA mRNA more ... | CTD | PMID:22935344 more ... |
Cebpa | Rat | rifampicin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [Rifampin affects the susceptibility to Dietary Fats] which results in decreased expression of CEBPA mRNA more ... | CTD | PMID:33412187 |
Cebpa | Rat | rimonabant | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Rimonabant inhibits the reaction [butylparaben results in increased expression of CEBPA mRNA] | CTD | PMID:27659731 |
Cebpa | Rat | risperidone | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA mRNA] and Berberine inhibits the reaction [Risperidone results in increased expression of CEBPA protein] | CTD | PMID:20564506 |
Cebpa | Rat | risperidone | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Risperidone results in increased expression of CEBPA mRNA and Risperidone results in increased expression of CEBPA protein | CTD | PMID:20564506 |
Cebpa | Rat | ritonavir | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of CEBPA protein] | CTD | PMID:11101056 |
Cebpa | Rat | rosmarinic acid | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | Rosmarinic Acid affects the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA mRNA] and Rosmarinic Acid inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of CEBPA protein] | CTD | PMID:33476690 |
Cebpa | Rat | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of CEBPA mRNA and Rotenone results in decreased expression of CEBPA protein | CTD | PMID:19693701 |
Cebpa | Rat | rottlerin | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | rottlerin inhibits the reaction [NSC606985 results in decreased expression of CEBPA protein] and rottlerin inhibits the reaction [NSC606985 results in increased ubiquitination of CEBPA protein] | CTD | PMID:19662097 |
Cebpa | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of CEBPA mRNA | CTD | PMID:35811015 |
Cebpa | Rat | SB 203580 | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | SB 203580 inhibits the reaction [Glucose results in increased localization of and results in increased activity of CEBPA protein] | CTD | PMID:24376792 |
Cebpa | Rat | selenium atom | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Selenium results in increased expression of CEBPA mRNA | CTD | PMID:28810182 |
Cebpa | Rat | sildenafil citrate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Sildenafil Citrate results in increased expression of CEBPA mRNA and Sildenafil Citrate results in increased expression of CEBPA protein | CTD | PMID:20471953 |
Cebpa | Rat | silibinin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CEBPA protein] | CTD | PMID:25559859 |
Cebpa | Rat | silicon dioxide | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of CEBPA mRNA and Silicon Dioxide results in decreased expression of CEBPA mRNA | CTD | PMID:25351596 and PMID:25895662 |
Cebpa | Rat | silicon dioxide | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of CEBPA mRNA | CTD | PMID:23806026 |
Cebpa | Rat | silver atom | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Silver results in decreased expression of CEBPA mRNA | CTD | PMID:26014281 |
Cebpa | Rat | silver(0) | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Silver results in decreased expression of CEBPA mRNA | CTD | PMID:26014281 |
Cebpa | Rat | sincalide | multiple interactions | EXP | | 6480464 | [Palmitic Acid co-treated with Sincalide] results in increased expression of CEBPA mRNA more ... | CTD | PMID:26873426 |
Cebpa | Rat | sirolimus | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Sirolimus results in decreased expression of CEBPA mRNA | CTD | PMID:15358118 |
Cebpa | Rat | sodium arsenate | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of CEBPA mRNA | CTD | PMID:32525701 |
Cebpa | Rat | sodium arsenite | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [sodium arsenite results in increased abundance of arsenite] which results in decreased expression of CEBPA mRNA and sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of CEBPA mRNA] | CTD | PMID:23152186 and PMID:32076005 |
Cebpa | Rat | sodium arsenite | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CEBPA mRNA | CTD | PMID:38568856 |
Cebpa | Rat | sodium arsenite | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CEBPA mRNA | CTD | PMID:29301061 and PMID:32844245 |
Cebpa | Rat | sodium arsenite | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of CEBPA mRNA | CTD | PMID:19822182 more ... |
Cebpa | Rat | sodium arsenite | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [sodium arsenite co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in decreased expression of CEBPA mRNA more ... | CTD | PMID:11812925 and PMID:34968464 |
Cebpa | Rat | sodium chloride | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Sodium Chloride results in increased expression of CEBPA mRNA | CTD | PMID:23634900 |
Cebpa | Rat | sodium dichromate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | sodium bichromate results in increased expression of CEBPA mRNA | CTD | PMID:31558096 |
Cebpa | Rat | stavudine | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Stavudine results in decreased expression of CEBPA protein | CTD | PMID:15722030 |
Cebpa | Rat | sunitinib | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Sunitinib results in increased expression of CEBPA mRNA | CTD | PMID:31533062 |
Cebpa | Rat | tacrolimus hydrate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | Tacrolimus results in increased expression of CEBPA mRNA | CTD | PMID:29362864 |
Cebpa | Rat | tamoxifen | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Tamoxifen results in decreased expression of CEBPA mRNA and Tamoxifen results in decreased expression of CEBPA protein | CTD | PMID:25123088 |
Cebpa | Rat | Tanshinone I | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [indirubin co-treated with tanshinone] promotes the reaction [tetraarsenic tetrasulfide results in increased expression of CEBPA protein] and [indirubin co-treated with tetraarsenic tetrasulfide] promotes the reaction [tanshinone results in increased expression of CEBPA protein] | CTD | PMID:18344322 |
Cebpa | Rat | Tanshinone I | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | tanshinone results in increased expression of CEBPA protein | CTD | PMID:18344322 |
Cebpa | Rat | taurine | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Taurine co-treated with 3-methyladenine] inhibits the reaction [1-nitropyrene results in decreased expression of CEBPA mRNA] | CTD | PMID:29078374 |
Cebpa | Rat | terbufos | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Fulvestrant inhibits the reaction [terbufos results in increased expression of CEBPA protein] | CTD | PMID:33872936 |
Cebpa | Rat | terbufos | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | terbufos results in increased expression of CEBPA protein | CTD | PMID:33872936 |
Cebpa | Rat | tert-butyl hydroperoxide | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | tert-Butylhydroperoxide affects the expression of CEBPA mRNA | CTD | PMID:23410634 |
Cebpa | Rat | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of CEBPA mRNA | CTD | PMID:21270424 |
Cebpa | Rat | testosterone | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Testosterone results in decreased expression of CEBPA mRNA and Testosterone results in decreased expression of CEBPA protein | CTD | PMID:12960001 |
Cebpa | Rat | tetrachloromethane | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Dinoprostone inhibits the reaction [PTGS1 gene mutant form promotes the reaction [Carbon Tetrachloride results in decreased expression of CEBPA protein]] more ... | CTD | PMID:20438794 and PMID:25432964 |
Cebpa | Rat | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of CEBPA mRNA | CTD | PMID:31150632 |
Cebpa | Rat | tetrachloromethane | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Carbon Tetrachloride results in decreased expression of CEBPA mRNA and Carbon Tetrachloride results in decreased expression of CEBPA protein | CTD | PMID:17484886 more ... |
Cebpa | Rat | Theaflavin 3,3'-digallate | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | theaflavin-3 and 3'-digallate affects the expression of CEBPA mRNA | CTD | PMID:34925699 |
Cebpa | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of CEBPA mRNA | CTD | PMID:23411599 and PMID:34492290 |
Cebpa | Rat | titanium dioxide | decreases methylation | ISO | Cebpa (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CEBPA gene and titanium dioxide results in decreased methylation of CEBPA promoter | CTD | PMID:35295148 |
Cebpa | Rat | titanium dioxide | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | titanium dioxide results in decreased expression of CEBPA mRNA | CTD | PMID:34973136 |
Cebpa | Rat | tolclofos-methyl | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Fulvestrant inhibits the reaction [tolclofos-methyl results in increased expression of CEBPA protein] | CTD | PMID:33872936 |
Cebpa | Rat | tolclofos-methyl | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | tolclofos-methyl results in increased expression of CEBPA protein | CTD | PMID:33872936 |
Cebpa | Rat | tolylfluanid | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | N-dichlorofluoromethylthio-N' and N'-dimethyl-N-p-tolylsulfamide results in increased expression of CEBPA mRNA | CTD | PMID:34801515 |
Cebpa | Rat | topiramate | decreases expression | EXP | | 6480464 | topiramate results in decreased expression of CEBPA mRNA | CTD | PMID:16979414 |
Cebpa | Rat | tributylstannane | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | tributyltin results in increased expression of CEBPA mRNA | CTD | PMID:25932594 and PMID:29787037 |
Cebpa | Rat | tributylstannane | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | T 0070907 inhibits the reaction [tributyltin results in increased expression of CEBPA mRNA] | CTD | PMID:29787037 |
Cebpa | Rat | tributylstannane | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | T 0070907 inhibits the reaction [tributyltin results in increased expression of CEBPA mRNA] | CTD | PMID:29787037 |
Cebpa | Rat | tributylstannane | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | tributyltin results in increased expression of CEBPA mRNA | CTD | PMID:28011154 and PMID:29787037 |
Cebpa | Rat | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of CEBPA mRNA | CTD | PMID:33387578 |
Cebpa | Rat | triclosan | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Triclosan results in decreased expression of CEBPA mRNA | CTD | PMID:15707987 |
Cebpa | Rat | triphenyl phosphate | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | triphenyl phosphate results in increased expression of CEBPA mRNA | CTD | PMID:28934090 |
Cebpa | Rat | triphenyl phosphate | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate analog] results in increased expression of CEBPA mRNA and [1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with triphenyl phosphate] results in increased expression of CEBPA mRNA | CTD | PMID:28437481 |
Cebpa | Rat | triphenyl phosphate | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | triphenyl phosphate results in increased expression of CEBPA mRNA | CTD | PMID:28163246 |
Cebpa | Rat | triptonide | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | triptonide results in increased expression of CEBPA mRNA | CTD | PMID:33045310 |
Cebpa | Rat | troglitazone | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:19022234 |
Cebpa | Rat | troglitazone | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | (+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Troglitazone] results in increased expression of CEBPA protein] more ... | CTD | PMID:26117538 |
Cebpa | Rat | troglitazone | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | troglitazone results in increased expression of CEBPA mRNA | CTD | PMID:12732648 more ... |
Cebpa | Rat | troglitazone | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with Troglitazone co-treated with INS protein] results in increased expression of CEBPA mRNA and Troglitazone inhibits the reaction [TNF protein inhibits the reaction [INS protein results in increased expression of CEBPA mRNA]] | CTD | PMID:27003841 and PMID:7956951 |
Cebpa | Rat | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of CEBPA mRNA | CTD | PMID:19022234 |
Cebpa | Rat | trovafloxacin | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide and E coli O55-B5] results in decreased expression of CEBPA mRNA | CTD | PMID:18930950 |
Cebpa | Rat | urethane | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Urethane results in decreased expression of CEBPA mRNA | CTD | PMID:28818685 |
Cebpa | Rat | valdecoxib | decreases expression | EXP | | 6480464 | valdecoxib results in decreased expression of CEBPA mRNA | CTD | PMID:24136188 |
Cebpa | Rat | valproic acid | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of CEBPA mRNA | CTD | PMID:29154799 and PMID:29501571 |
Cebpa | Rat | valproic acid | decreases methylation | ISO | CEBPA (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of CEBPA gene | CTD | PMID:29501571 |
Cebpa | Rat | valproic acid | increases methylation | ISO | CEBPA (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of CEBPA gene | CTD | PMID:29154799 |
Cebpa | Rat | valproic acid | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein affects the reaction [Valproic Acid results in decreased expression of CALR mRNA] more ... | CTD | PMID:32623605 |
Cebpa | Rat | valproic acid | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CEBPA mRNA | CTD | PMID:19101580 |
Cebpa | Rat | valsartan | decreases expression | ISO | CEBPA (Homo sapiens) | 6480464 | Valsartan results in decreased expression of CEBPA mRNA | CTD | PMID:22768174 |
Cebpa | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of CEBPA mRNA | CTD | PMID:23034163 |
Cebpa | Rat | vitamin D | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [Vitamin D co-treated with bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] affects the expression of CEBPA mRNA | CTD | PMID:33836827 |
Cebpa | Rat | vitamin E | multiple interactions | ISO | Cebpa (Mus musculus) | 6480464 | Vitamin E inhibits the reaction [Ethanol results in decreased activity of CEBPA protein] and Vitamin E inhibits the reaction [Ethanol results in decreased expression of CEBPA protein] | CTD | PMID:16737972 |
Cebpa | Rat | wogonin | increases expression | ISO | Cebpa (Mus musculus) | 6480464 | wogonin analog results in increased expression of CEBPA protein and wogonin results in increased expression of CEBPA protein | CTD | PMID:30445784 |
Cebpa | Rat | zearalenone | affects expression | ISO | CEBPA (Homo sapiens) | 6480464 | Zearalenone affects the expression of CEBPA mRNA | CTD | PMID:28865950 |
Cebpa | Rat | zearalenone | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | [deoxynivalenol co-treated with Zearalenone] results in decreased expression of CEBPA mRNA | CTD | PMID:28865950 |
Cebpa | Rat | zidovudine | decreases expression | ISO | Cebpa (Mus musculus) | 6480464 | Zidovudine results in decreased expression of CEBPA protein | CTD | PMID:15722030 |
Cebpa | Rat | zinc atom | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA] and CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] | CTD | PMID:15389791 and PMID:17363595 |
Cebpa | Rat | zinc atom | increases response to substance | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein results in increased susceptibility to Zinc | CTD | PMID:15389791 |
Cebpa | Rat | zinc(0) | multiple interactions | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein inhibits the reaction [Zinc results in increased expression of MT2A mRNA] and CEBPA protein promotes the reaction [MTF1 protein promotes the reaction [Zinc results in increased expression of MT2A mRNA]] | CTD | PMID:15389791 and PMID:17363595 |
Cebpa | Rat | zinc(0) | increases response to substance | ISO | CEBPA (Homo sapiens) | 6480464 | CEBPA protein results in increased susceptibility to Zinc | CTD | PMID:15389791 |
Cebpa | Rat | zoledronic acid | increases expression | ISO | CEBPA (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of CEBPA mRNA | CTD | PMID:20977926 |